BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 18310948)

  • 1. Estimation of L-dopa from Mucuna pruriens LINN and formulations containing M. pruriens by HPTLC method.
    Modi KP; Patel NM; Goyal RK
    Chem Pharm Bull (Tokyo); 2008 Mar; 56(3):357-9. PubMed ID: 18310948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Determination of L-DOPA in Seeds of Mucuna Pruriens Germplasm by High Performance Thin Layer Chromatography.
    Raina AP; Khatri R
    Indian J Pharm Sci; 2011 Jul; 73(4):459-62. PubMed ID: 22707835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of Levodopa in the Unani Drug Mucuna pruriens Bak. and Its Marketed Formulation by High-Performance Thin-Layer Chromatographic Technique.
    Mohapatra S; Ganguly P; Singh R; Katiyar CK
    J AOAC Int; 2020 Jun; 103(3):678-683. PubMed ID: 31540588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative determination of L-DOPA in tablets by high performance thin layer chromatography.
    Mennickent S; Nail M; Vega M; de Diego M
    J Sep Sci; 2007 Aug; 30(12):1893-8. PubMed ID: 17638351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Electrochemical Method for the Determination of L-DOPA in Extract From the Seeds of Mucuna Prurita.
    Stankovič DM; Samphao A; Dojcinović B; Kalcher K
    Acta Chim Slov; 2016; 63(2):220-6. PubMed ID: 27333543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative NMR analysis of L-Dopa in seeds from two varieties of Mucuna pruriens.
    Fernandez-Pastor I; Luque-Muñoz A; Rivas F; Medina-O'Donnell M; Martinez A; Gonzalez-Maldonado R; Haidour A; Parra A
    Phytochem Anal; 2019 Jan; 30(1):89-94. PubMed ID: 30216583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on quality standard of Mucuna pruriens var. utilis].
    Wu SH; Jiang WZ; Lv L; Wu LL; Lv C; Shi XX; Su GL
    Zhong Yao Cai; 2009 Mar; 32(3):333-5. PubMed ID: 19565706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levodopa in Mucuna pruriens and its degradation.
    Pulikkalpura H; Kurup R; Mathew PJ; Baby S
    Sci Rep; 2015 Jun; 5():11078. PubMed ID: 26058043
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Kamkaen N; Chittasupho C; Vorarat S; Tadtong S; Phrompittayarat W; Okonogi S; Kwankhao P
    Molecules; 2022 May; 27(10):. PubMed ID: 35630617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a thin-layer chromatography-densitometric method for the quantitation of alliin from garlic (Allium sativum) and its formulations.
    Kanaki NS; Rajani M
    J AOAC Int; 2005; 88(5):1568-70. PubMed ID: 16386011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extraction of bioactive principles from Mucuna pruriens seeds.
    Misra L; Wagner H
    Indian J Biochem Biophys; 2007 Feb; 44(1):56-60. PubMed ID: 17385342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enantiomeric determination of DOPA in dietary supplements containing Mucuna pruriens by liquid chromatography/mass spectrometry.
    Hasegawa T; Takahashi K; Fukiwake T; Saijo M; Motoki Y
    Shokuhin Eiseigaku Zasshi; 2013; 54(5):379-83. PubMed ID: 24190293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme (ACE) inhibitory potential of standardized Mucuna pruriens seed extract.
    Chaudhary SK; De A; Bhadra S; Mukherjee PK
    Pharm Biol; 2015; 53(11):1614-20. PubMed ID: 25868619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Physicochemical Stability of the L-DOPA Extract of
    Vilairat C; Kobtrakul K; Vimolmangkang S
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of berberine in ayurvedic formulations containing Berberis aristata.
    Rout KK; Pradhan S; Mishra SK
    J AOAC Int; 2008; 91(5):1149-53. PubMed ID: 18980133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study.
    Katzenschlager R; Evans A; Manson A; Patsalos PN; Ratnaraj N; Watt H; Timmermann L; Van der Giessen R; Lees AJ
    J Neurol Neurosurg Psychiatry; 2004 Dec; 75(12):1672-7. PubMed ID: 15548480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucuna pruriens in Parkinson Disease: A Kinetic-Dynamic Comparison With Levodopa Standard Formulations.
    Contin M; Lopane G; Passini A; Poli F; Iannello C; Guarino M
    Clin Neuropharmacol; 2015; 38(5):201-3. PubMed ID: 26366963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPTLC method for guggulsterone. I. Quantitative determination of E- and Z-guggulsterone in herbal extract and pharmaceutical dosage form.
    Agrawal H; Kaul N; Paradkar AR; Mahadik KR
    J Pharm Biomed Anal; 2004 Sep; 36(1):33-41. PubMed ID: 15351045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of trans-resveratrol in herbal extracts and dosage forms by high-performance thin-layer chromatography.
    Babu SK; Kumar KV; Subbaraju GV
    Chem Pharm Bull (Tokyo); 2005 Jun; 53(6):691-3. PubMed ID: 15930785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease.
    Kasture S; Pontis S; Pinna A; Schintu N; Spina L; Longoni R; Simola N; Ballero M; Morelli M
    Neurotox Res; 2009 Feb; 15(2):111-22. PubMed ID: 19384573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.